BRIEF-Moderna Provides Update On BLA Submission For Combination Vaccine Against Influenza And Covid-19

Reuters
21 May
BRIEF-Moderna Provides Update On BLA Submission For Combination Vaccine Against Influenza And Covid-19

May 21 (Reuters) - Moderna Inc MRNA.O:

  • MODERNA PROVIDES UPDATE ON BLA SUBMISSION FOR COMBINATION VACCINE AGAINST INFLUENZA AND COVID-19

  • MODERNA - VOLUNTARILY WITHDRAWN PENDING BLA FOR MRNA-1083, ITS FLU/COVID COMBINATION VACCINE CANDIDATE FOR ADULTS AGED 50 YEARS AND OLDER

  • MODERNA: PLANS TO RESUBMIT BLA LATER THIS YEAR

  • MODERNA: CONTINUES TO EXPECT INTERIM DATA FROM MRNA-1010 TRIAL TO BE AVAILABLE THIS SUMMER

Source text: [ID:]

Further company coverage: MRNA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10